
Vriglim-MP 2 Tablet SR
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vriglim-MP 2 Tablet SR
Diabex-Duo 2mg Extended Release tablets combine medications to manage blood glucose. This treatment, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and duration; take with food to minimize digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume your regular schedule. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals raises the hypoglycemia risk; monitor your blood sugar closely. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting, inform your doctor of any kidney, liver, or heart conditions. Pregnant or breastfeeding individuals require prior medical consultation. Kidney function will be assessed before treatment begins. Limit alcohol consumption as it may heighten the chance of side effects.
Primary Ingredients of Vriglim-MP 2 Tablet SR
No text was provided to rewrite.
Uses of Vriglim-MP 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Vriglim-MP 2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vriglim-MP 2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Vriglim-MP 2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vriglim-MP 2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vriglim-MP 2 Tablet SR should be administered with a meal.
How Vriglim-MP 2 Tablet SR works:
Vriglim-MP 2 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vriglim-MP 2 Tablet SR and alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Vriglim-MP 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vriglim-MP 2 tablets should likely be avoided while breastfeeding. Scant evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Vriglim-MP 2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Vriglim-MP 2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Exercise caution when administering Vriglim-MP 2 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before use. Vriglim-MP 2 Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Vriglim-MP 2 Tablet SR :
Should you forget a Vriglim-MP 2 Tablet SR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vriglim-MP 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
